The intricate network, which positively and negatively regulates GBM invasiveness, has been extensively studied to develop therapeutic approaches, including the PI3K/Akt, Wnt, SHH-GLI1, and microRNAs [98]. This evidence concerns the gene AKT1 and glioblastoma.